ES2080764T3 - Derivados de acidos biliares fluorados, procedimientos para su preparacion y composiciones farmaceuticas que los contienen. - Google Patents

Derivados de acidos biliares fluorados, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.

Info

Publication number
ES2080764T3
ES2080764T3 ES90106971T ES90106971T ES2080764T3 ES 2080764 T3 ES2080764 T3 ES 2080764T3 ES 90106971 T ES90106971 T ES 90106971T ES 90106971 T ES90106971 T ES 90106971T ES 2080764 T3 ES2080764 T3 ES 2080764T3
Authority
ES
Spain
Prior art keywords
derivatives
fluorated
procedures
contain
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90106971T
Other languages
English (en)
Inventor
Roberto Pellicciari
Aldo Roda
Giuliano Frigerio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Giuliani SpA
Original Assignee
Giuliani SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giuliani SpA filed Critical Giuliani SpA
Application granted granted Critical
Publication of ES2080764T3 publication Critical patent/ES2080764T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

UNOS COMPUESTOS DE FORMULA GENERAL I EN DONDE R1 ES HIDROGENO O HIDROXILO, Y EL GRUPO HIDROXILO DE LA POSICION 7 PUEDE ESTAR EN CONFIGURACION (ALFA) O (BETA), SON VALIDOS EN TERAPIA HUMANA. LOS COMPUESTOS SE PUEDEN PREPARAR POR FLUORACION DE LOS ADECUADOS 6-HIDROXILO-7-KETO DERIVADOS PROTEGIDOS.
ES90106971T 1989-04-17 1990-04-11 Derivados de acidos biliares fluorados, procedimientos para su preparacion y composiciones farmaceuticas que los contienen. Expired - Lifetime ES2080764T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8920170A IT1229570B (it) 1989-04-17 1989-04-17 Derivati fluorurati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.

Publications (1)

Publication Number Publication Date
ES2080764T3 true ES2080764T3 (es) 1996-02-16

Family

ID=11164384

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90106971T Expired - Lifetime ES2080764T3 (es) 1989-04-17 1990-04-11 Derivados de acidos biliares fluorados, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.

Country Status (10)

Country Link
US (1) US5061701A (es)
EP (1) EP0393493B1 (es)
JP (1) JP3122448B2 (es)
AT (1) ATE131173T1 (es)
CA (1) CA2014545C (es)
DE (1) DE69023947T2 (es)
DK (1) DK0393493T3 (es)
ES (1) ES2080764T3 (es)
GR (1) GR3018387T3 (es)
IT (1) IT1229570B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175320A (en) * 1989-04-17 1992-12-29 Giuliani S.P.A. Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
DK0688333T3 (da) * 1993-03-10 1999-02-08 Magainin Pharma Steroidderivater, farmaceutiske præparater indeholdende disse og deres anvendelse som antibiotika eller desinfektionsmidler
US5856535A (en) * 1994-08-18 1999-01-05 Magainin Pharmaceuticals, Inc. Aminosterol ester compounds
US5840740A (en) * 1995-06-07 1998-11-24 Magainin Pharmaceuticals Inc. Aminosterol compounds and a method of treating infection using the aminosterol compounds
US5763430A (en) * 1995-06-07 1998-06-09 Magainin Pharmaceuticals Inc. Method of treating a viral infection by administering a steroid compound
US5994336A (en) * 1995-06-07 1999-11-30 Magainin Pharmaceuticals Inc. Method of inhibiting proliferation of cells by administering an aminosterol compound
US5795885A (en) * 1995-06-07 1998-08-18 Magainin Pharmaceuticals Inc. Method of inhibiting profileration of cells by administering an aminosterol compound
US5847172A (en) * 1995-06-07 1998-12-08 Magainin Pharmaceuticals Inc. Certain aminosterol compounds and pharmaceutical compositions including these compounds
US6143738A (en) * 1995-06-07 2000-11-07 Magainin Pharmaceuticals, Inc. Therapeutic uses for an aminosterol compound
US5792635A (en) * 1995-06-07 1998-08-11 Magainin Pharmaceuticals, Inc. Method of inhibiting the sodium/proton exchanger NHE3 and method of inhibiting growth by administering squalamine
US5874597A (en) * 1995-06-07 1999-02-23 Magainin Pharmaceuticals, Inc. Certain aminosterol compounds and pharmaceutical compositions including these compounds
US5840936A (en) * 1995-06-07 1998-11-24 Magainin Pharmaceuticals Inc. Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE)
WO1997040835A1 (en) * 1996-04-26 1997-11-06 Magainin Pharmaceuticals Inc. Treatment of carcinomas using squalamine in combination with other anti-cancer agents
US6596712B2 (en) 1996-04-26 2003-07-22 Genaera Corporation Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities
US6262283B1 (en) 1996-12-06 2001-07-17 Magainin Pharmaceuticals Inc. Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds
PT1274718E (pt) * 2000-04-12 2007-01-31 Genaera Corp Processo para a preparação de esteróis 7. alfa-hidroxi 3- aminosubstítuidos utilizando intermediários com um grupo 7. alfa-hidroxilo desprotegido
DK1392714T3 (da) 2001-03-12 2006-01-09 Intercept Pharmaceuticals Inc Steroider som agonister for FXR
ITMI20021532A1 (it) * 2002-07-12 2004-01-12 Roberto Pellicciari Composti chimici
PL1734970T3 (pl) 2004-03-12 2015-05-29 Intercept Pharmaceuticals Inc Leczenie zwłóknienia z zastosowaniem ligandów FXR
US10987362B2 (en) 2004-03-12 2021-04-27 Intercept Pharmaceuticals, Inc. Treatment of fibrosis using FXR ligands
ITMI20050912A1 (it) * 2005-05-19 2006-11-20 Erregierre Spa Processo di preparazione di acidi 3-a-ya(b)-diidrossi-6-a(b)-alchil-5b-colanici
JP5292310B2 (ja) 2007-01-19 2013-09-18 インターセプト ファーマシューティカルズ， インコーポレイテッド Ｔｇｒ５調節剤としての２３−置換胆汁酸およびその使用方法
EA020310B1 (ru) 2008-07-30 2014-10-30 Интерсепт Фармасьютикалз, Инк. Модуляторы рецептора tgr5 и их применение
ES2458168T3 (es) 2008-11-19 2014-04-30 Intercept Pharmaceuticals, Inc. Moduladores de TGR5 y método de uso de los mismos
CN104781272A (zh) 2012-06-19 2015-07-15 英特塞普特医药品公司 奥贝胆酸的制备、用途和固体形式
US9982008B2 (en) 2012-06-19 2018-05-29 Intercept Pharmaceuticals, Inc. Preparation and uses of obeticholic acid
BR112016002268B1 (pt) 2013-08-01 2022-11-01 The Penn State Research Foundation Uso de inibidores do receptor x farnesoide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460509A (en) * 1981-08-19 1984-07-17 Beth Israel Medical Center Chemical synthesis
US4545938A (en) * 1983-11-02 1985-10-08 Beth Israel Medical Center Chemical synthesis
US4648995A (en) * 1983-11-02 1987-03-10 Beth Israel Medical Center Chemical synthesis

Also Published As

Publication number Publication date
JP3122448B2 (ja) 2001-01-09
JPH02292300A (ja) 1990-12-03
EP0393493A2 (en) 1990-10-24
DK0393493T3 (da) 1996-04-15
CA2014545A1 (en) 1990-10-17
ATE131173T1 (de) 1995-12-15
CA2014545C (en) 2001-08-14
EP0393493A3 (en) 1992-05-27
IT8920170A0 (it) 1989-04-17
DE69023947T2 (de) 1996-05-30
GR3018387T3 (en) 1996-03-31
IT1229570B (it) 1991-09-04
US5061701A (en) 1991-10-29
EP0393493B1 (en) 1995-12-06
DE69023947D1 (de) 1996-01-18

Similar Documents

Publication Publication Date Title
ES2080764T3 (es) Derivados de acidos biliares fluorados, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
ES2074492T3 (es) Derivados de acidos biliares, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2009723T3 (es) Derivados de acidos biliares, procedimientos para la preparacion de los mismos y composiciones farmaceuticas conteniendolos.
MX9301929A (es) Derivados de pirimidina y procedimientos para su preparacion.
BRPI0412527A (pt) composto, uso do mesmo, composição farmacêutica, formulação farmacêutica em aerossol, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica, e, processo para preparar um composto.
ES2039278T3 (es) Procedimiento para preparar inhibidores de 5-alfa-reductasa de esteroides.
ES2059335T3 (es) Derivados de pirido(3,2,1-ij)-1,3,4-benzoxadiazina, procedimiento para su obtencion, preparados farmaceuticos correspondientes y productos intermedios utilizables en el procedimiento.
ES2083123T3 (es) Nuevos derivados de aril-etil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2012809B3 (es) Derivados del taxol, su preparacion y composiciones farmaceuticas que los contienen.
ES2147567T3 (es) El empleo de oxidos de 1,2,4-benzotriazina para la preparacion de un medicamento para el tratamiento de tumores.
DK0427411T3 (da) Lysbeskyttelsesmiddel med forbedret bestandighed
ES2059557T3 (es) Nuevas bis-(3,5-dicarbamoil-2,4,6-triyodo-anilidas) de acidos dicarboxilicos, procedimiento para su preparacion asi como agentes de contraste de rayos x que contienen a estos.
ES2001152A4 (es) Preparados cosmeticos a base de n - hidroxibutil - quitosanas, nuevasn - hidroxibutil - quitosanas, asi como el procedimiento para su obtencion.
AR011957A1 (es) Derivados de dolastatina 15 con funcionalidades carbonilo y heterociclicas en el c-terminal
KR870700599A (ko) 카르복실산유도체, 그의 제조방법, 이화합물을 함유한 약제조성물 및 그의 용도
ES2138613T3 (es) Derivado de espirooxatiolano-quinuclidina para el tratamiento del sindrome de sjoegren.
DK84181A (da) Derivater af 3,4,5-trihydroxypiperidin,fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler samt til dyreernaering
CO4940430A1 (es) Compuestos policiclicos que contienen estaurosporina hidrogenada con propiedades farmacologicas convenientes y un efecto inhibidor sobre el crecimiento de las celulas tumorales
BR0008302A (pt) Uso de um derivado de benzaldeìdo, derivado de benzaldeìdo, composição farmacêutica, e, processo para a fabricação da mesma
ES2032335T3 (es) Nuevos derivados flavonoides 2-piperazinil-2-oxo-etilen sustituidos, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
ES2064328T3 (es) Indolilpropanoles, procedimiento para su fabricacion y su uso, asi como preparaciones que contienen los compuestos.
ES2066546T3 (es) Composicion farmaceutica para inhibir la resorcion osea.
BR9912816A (pt) Composição terapêutica à base de flavonóides, tencionada para uso no tratamento de tumores por agentes citotóxicos
IT7850986A0 (it) 5-imminodaunomicina e suoi derivati procedimento per prepararla nonche'composizioni farmaceutiche che la contengono
ES2129893T3 (es) Dinucleosido-5',5'-pirofosfatos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 393493

Country of ref document: ES